Mbx Biosciences earnings were -$104.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest MBX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$37.1M, up 57.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MBX reported annual earnings of -$87.0M, with 40.5% growth.
What were Mbx Biosciences's earnings last quarter?
On MBX's earnings call on Aug 6, 2026, Mbx Biosciences (NASDAQ: MBX) reported Q2 2026 earnings per share (EPS) of -$0.78, up 34.48% year over year. Total MBX earnings for the quarter were -$37.10 million. In the same quarter last year, Mbx Biosciences's earnings per share (EPS) was -$0.58.
As of the last Mbx Biosciences earnings report, Mbx Biosciences is currently losing money. Mbx Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$104.29 million, a 35.41% increase year over year.
What was MBX's earnings growth in the past year?
As of Mbx Biosciences's earnings date in Aug 6, 2026, Mbx Biosciences's earnings has grown year over year. MBX earnings in the past year totalled -$104.29 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.